Prediction of Drug Metabolites Using Neural Machine Translation

20 May 2020, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

We present an end-to-end learning-based method for predicting possible human metabolites of small molecules including drugs. The metabolite prediction task is approached as a sequence translation problem with chemical compounds represented using the SMILES notation. We perform transfer leaning on a Seq2Seq Transformer model originally trained on chemical reaction data to predict the outcome of human metabolic reactions. We further build an ensemble model to account for multiple and diverse metabolites.
Extensive evaluation reveals that the proposed method generalizes well to different enzyme families, as it can correctly predict metabolites for phase I and phase II drug metabolism reactions as well as for other enzymes.

Keywords

Drug Metabolites
Neural Machine Translation
Transformer model

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.